Canopy Growth (CGC) Debuts 7ACRES Cannabis Line In Australia

Canopy Growth Corporation (NASDAQ:CGC) is one of the best meme stocks. On August 5, CGC revealed that it is launching its 7ACRES cannabis brand in Australia, introducing two high-THC sativa strains to its medical cannabis lineup.

The company released two strains, Ultra Jack and Jack Frost, both sold in 10-gram flower packs. Ultra Jack comes from crossing Ultra Sour with Jack Haze, while Jack Frost mixes White Widow and Cold Creek Kush.

Canopy Growth expanded its presence in Australia by launching the 7ACRES brand, adding to its existing products like Tweed flower and Spectrum Therapeutics oils, which come in Red, Yellow, White, and Blue options.

Andrew Bevan, Canopy Growth Corporation (NASDAQ:CGC)’s SVP of Global Medical, commented that adding 7ACRES in Australia gives patients and doctors more options for quality cannabis products. Similarly, CEO Luc Mongeau mentioned that global medical is one of Canopy Growth’s biggest business opportunities.

Canopy Growth Corporation is a Canadian company that develops and sells cannabis, hemp, and related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, Storz & Bickel, and This Works.

While we acknowledge the potential of CGC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Dow 20 Stocks List: Ranked By Hedge Fund Bullishness Index and 10 Unstoppable Dividend Stocks to Buy Now.

Disclosure. None.